Onkos Surgical wins FDA de novo nod for antibacterial-coated orthopedic implants
April 9, 2024
Onkos Surgical this week announced it received FDA de novo approval for its antibacterial coated implants.
Onkos Surgical this week announced it received FDA de novo approval for its antibacterial coated implants.
Vivos Therapeutics specializes in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (OSA) in adults).
Medical Microinstruments said the system could increase the number of physicians who can perform complicated microsurgical procedures.
Neurovalens announced today that it received FDA clearance for its Modius Stress device for treating anxiety and raised $2.65 million.
Orthobond has secured FDA de novo approval for its Ostaguard antibacterial technology that could one day be used for a wide range of medical devices — and beyond medtech.
Siemens Healthineers announced today that it received FDA 510(k) clearance for its MammoMat B.brilliant mammography platform.
The clearance adds to the list of devices the FDA has authorized this year with AI algorithms to detect health conditions.
The CEO of Prenosis told MedTech Dive the company sees third-party validation as important, with the FDA having clarified that certain decision support tools should be regulated as medical devices.
TEG testing provides critical information that can help physicians improve hemostasis management for their patients
HeadaTerm 2 uses neuromodulation technology. It releases targeted electrical impulses that increase the pain tolerance of the wearer.